{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:28:35Z","timestamp":1789050515690,"version":"build-2803163510"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Acute respiratory infections (ARIs) account for most outpatient visits. Discriminating bacterial vs viral etiology is a diagnostic challenge with therapeutic implications.<\/jats:p><\/jats:sec>Objective<\/jats:title>To investigate whether FebriDx, a rapid, point-of-care immunoassay, can differentiate bacterial- from viral-associated host immune response in ARI through measurement of myxovirus resistance protein A (MxA) and C-reactive protein (CRP) from finger-stick blood.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This diagnostic study enrolled adults and children who were symptomatic for ARI and individuals in a control group who were asymptomatic between October 2019 and April 2021. Included participants were a convenience sample of patients in outpatient settings (ie, emergency department, urgent care, and primary care) who were symptomatic, aged 1 year or older, and had suspected ARI and fever within 72 hours. Individuals with immunocompromised state and recent vaccine, antibiotics, stroke, surgery, major burn, or myocardial infarction were excluded. Of 1685 individuals assessed for eligibility, 259 individuals declined participation, 718 individuals were excluded, and 708 individuals were enrolled (520 patients with ARI, 170 patients without ARI, and 18 individuals who dropped out).<\/jats:p><\/jats:sec>Exposures<\/jats:title>Bacterial and viral immunoassay testing was performed using finger-stick blood. Results were read at 10 minutes, and treating clinicians and adjudicators were blinded to results.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Bacterial- or viral-associated systemic host response to an ARI as determined by a predefined comparator algorithm with adjudication classified infection etiology.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 520 participants with ARI (230 male patients [44.2%] and 290 female patients [55.8%]; mean [SD] age, 35.3 [17.7] years), 24 participants with missing laboratory information were classified as unknown (4.6%). Among 496 participants with a final diagnosis, 73 individuals (14.7%) were classified as having a bacterial-associated response, 296 individuals (59.7%) as having a viral-associated response, and 127 individuals (25.6%) as negative by the reference standard. The bacterial and viral test correctly classified 68 of 73 bacterial infections, demonstrating a sensitivity of 93.2% (95% CI, 84.9%-97.0%), specificity of 374 of 423 participants (88.4% [95% CI, 85.0%-91.1%]), positive predictive value (PPV) of 68 of 117 participants (58.1% [95% CI, 49.1%-66.7%), and negative predictive value (NPV) of 374 of 379 participants (98.7% [95% CI, 96.9%-99.4%]).The test correctly classified 208 of 296 viral infections, for a sensitivity of 70.3% (95% CI, 64.8%-75.2%), a specificity of 176 of 200 participants (88.0% [95% CI, 82.8%-91.8%]), a PPV of 208 of 232 participants (89.7% [95% CI, 85.1%-92.9%]), and an NPV of 176 of 264 participants (66.7% [95% CI, 60.8%-72.1%]).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study, a rapid diagnostic test demonstrated diagnostic performance that may inform clinicians when assessing for bacterial or viral etiology of ARI symptoms.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.34588","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T15:26:06Z","timestamp":1666106766000},"page":"e2234588","source":"Crossref","is-referenced-by-count":43,"title":["Diagnostic Accuracy of a Bacterial and Viral Biomarker Point-of-Care Test in the Outpatient Setting"],"prefix":"10.1001","volume":"5","author":[{"given":"Nathan I.","family":"Shapiro","sequence":"first","affiliation":[{"name":"Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Filbin","sequence":"additional","affiliation":[{"name":"Emergency Medicine, Massachusetts General Hospital Institute for Patient Care, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Hou","sequence":"additional","affiliation":[{"name":"Division of Emergency Critical Care Medicine, Department of Emergency Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Kurz","sequence":"additional","affiliation":[{"name":"Emergency Medicine, University of Alabama School of Medicine, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin H.","family":"Han","sequence":"additional","affiliation":[{"name":"Geriatric Research, Education, and Clinical Center, Tennessee Valley Healthcare Center, Nashville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom P.","family":"Aufderheide","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Ward","sequence":"additional","affiliation":[{"name":"BerbeeWalsh Department of Emergency Medicine, University of Wisconsin School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Pulia","sequence":"additional","affiliation":[{"name":"BerbeeWalsh Department of Emergency Medicine, University of Wisconsin School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Birkhahn","sequence":"additional","affiliation":[{"name":"Emergency Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Diaz","sequence":"additional","affiliation":[{"name":"Internal Medicine, Doral Medical Research, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teena L.","family":"Hughes","sequence":"additional","affiliation":[{"name":"PAS Research, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manya R.","family":"Harsch","sequence":"additional","affiliation":[{"name":"Statistical Analysis, Technomics Research, Long Lake, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Bell","sequence":"additional","affiliation":[{"name":"Medical Affairs, Lumos Diagnostics, Sarasota, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Suarez-Cuervo","sequence":"additional","affiliation":[{"name":"Medical Affairs, Lumos Diagnostics, Sarasota, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sambursky","sequence":"additional","affiliation":[{"name":"Medical Affairs, Lumos Diagnostics, Sarasota, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"issue":"6","key":"zoi220987r2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.7326\/M15-1840","article-title":"Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention.","volume":"164","author":"Harris","year":"2016","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi220987r3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","author":"Lower Respiratory Infections Collaborators","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"zoi220987r4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw045","article-title":"Unnecessary antibiotics for acute respiratory tract infections: association with care setting and patient demographics.","volume":"3","author":"Barlam","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"zoi220987r5","doi-asserted-by":"publisher","first-page":"e180243","DOI":"10.1001\/jamanetworkopen.2018.0243","article-title":"Outpatient antibiotic prescribing for acute respiratory infections during influenza seasons.","volume":"1","author":"Havers","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi220987r6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12875-019-0980-1","article-title":"Antibiotic prescribing for acute respiratory tract infections in the United States outpatient setting.","volume":"20","author":"Shaver","year":"2019","journal-title":"BMC Fam Pract"},{"issue":"9","key":"zoi220987r7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/jamainternmed.2018.1632","article-title":"Comparison of antibiotic prescribing in retail clinics, urgent care centers, emergency departments, and traditional ambulatory care settings in the United States.","volume":"178","author":"Palms","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"2","key":"zoi220987r8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.36469\/00001","article-title":"Economic evaluation of FebriDx: a novel rapid, point-of-care test for differentiation of viral versus bacterial acute respiratory infection in the United States.","volume":"8","author":"Dick","year":"2021","journal-title":"J Health Econ Outcomes Res"},{"issue":"2","key":"zoi220987r9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/cid\/cix323","article-title":"Procalcitonin: the right answer but to which question?","volume":"65","author":"Bergin","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi220987r11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.anpedi.2017.06.001","volume":"88","author":"Croche Santander","year":"2018","journal-title":"An Pediatr (Engl Ed)"},{"issue":"8","key":"zoi220987r12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003208","article-title":"Variation in antibiotic prescription rates in febrile children presenting to emergency departments across Europe (MOFICHE): a multicentre observational study.","volume":"17","author":"Hagedoorn","year":"2020","journal-title":"PLoS Med"},{"issue":"3","key":"zoi220987r13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.anpedi.2020.11.019","volume":"96","author":"Garc\u00eda-Moreno","year":"2021","journal-title":"An Pediatr (Engl Ed)"},{"issue":"3","key":"zoi220987r14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/fampra\/cmw019","article-title":"Necessity of office visits for acute respiratory infections in primary care.","volume":"33","author":"Renati","year":"2016","journal-title":"Fam Pract"},{"issue":"9","key":"zoi220987r15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006089.pub5","article-title":"Antibiotics for acute rhinosinusitis in adults.","volume":"9","author":"Lemiengre","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"zoi220987r16","doi-asserted-by":"publisher","first-page":"28245","DOI":"10.3402\/ecrj.v2.28245","article-title":"Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and\/or bacterial immune response in patients with acute febrile respiratory infection.","volume":"2","author":"Sambursky","year":"2015","journal-title":"Eur Clin Respir J"},{"issue":"6","key":"zoi220987r17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1373\/clinchem.2018.292391","article-title":"Interferon-inducible myxovirus resistance proteins: potential biomarkers for differentiating viral from bacterial infections.","volume":"65","author":"Zav\u2019yalov","year":"2019","journal-title":"Clin Chem"},{"issue":"50","key":"zoi220987r18","doi-asserted-by":"publisher","first-page":"29893","DOI":"10.1074\/jbc.M115.681494","article-title":"Oligomerization and GTP-binding requirements of MxA for viral target recognition and antiviral activity against influenza a virus.","volume":"290","author":"Nigg","year":"2015","journal-title":"J Biol Chem"},{"issue":"2","key":"zoi220987r19","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy024","article-title":"Outpatient antibiotic stewardship: a growing frontier-combining myxovirus resistance protein a with other biomarkers to improve antibiotic use.","volume":"5","author":"Joseph","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"zoi220987r20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1086\/421997","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.","volume":"39","author":"Simon","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"8","key":"zoi220987r21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/INF.0b013e31806215e3","article-title":"Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department.","volume":"26","author":"Andreola","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"zoi220987r22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/07853890.2018.1474002","article-title":"A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever.","volume":"50","author":"Shapiro","year":"2018","journal-title":"Ann Med"},{"issue":"3","key":"zoi220987r23","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.v75.3","article-title":"Utility of the FebriDx point-of-care test for rapid triage and identification of possible coronavirus disease 2019 (COVID-19).","volume":"75","author":"Karim","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"5","key":"zoi220987r24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cmi.2014.12.026","article-title":"The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis.","volume":"21","author":"Hoeboer","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"zoi220987r25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/cid\/cix317","article-title":"Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia.","volume":"65","author":"Self","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi220987r26","doi-asserted-by":"publisher","first-page":"e985","DOI":"10.1542\/peds.2014-1946","article-title":"Diagnosis of viral infections using myxovirus resistance protein A (MxA).","volume":"135","author":"Engelmann","year":"2015","journal-title":"Pediatrics"},{"issue":"12","key":"zoi220987r27","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update.","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"issue":"9","key":"zoi220987r28","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9090610","article-title":"Point-of-care C-reactive protein testing to reduce antibiotic prescribing for respiratory tract infections in primary care: systematic review and meta-analysis of randomised controlled trials.","volume":"9","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"754","key":"zoi220987r29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection.","volume":"9","author":"Sproston","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"zoi220987r30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0166-0934(97)00177-8","article-title":"The MxA protein levels in whole blood lysates of patients with various viral infections.","volume":"70","author":"Chieux","year":"1998","journal-title":"J Virol Methods"},{"issue":"6-7","key":"zoi220987r31","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.biochi.2007.04.015","article-title":"Interferon-induced Mx proteins in antiviral host defense.","volume":"89","author":"Haller","year":"2007","journal-title":"Biochimie"},{"issue":"6","key":"zoi220987r32","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1203\/01.pdr.0000246098.65888.5b","article-title":"MxA-based recognition of viral illness in febrile children by a whole blood assay.","volume":"60","author":"Nakabayashi","year":"2006","journal-title":"Pediatr Res"},{"key":"zoi220987r33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jcv.2014.11.018","article-title":"Blood MxA protein as a marker for respiratory virus infections in young children.","volume":"62","author":"Toivonen","year":"2015","journal-title":"J Clin Virol"},{"issue":"4","key":"zoi220987r34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.06.051","article-title":"Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19.","volume":"81","author":"Clark","year":"2020","journal-title":"J Infect"},{"key":"zoi220987r35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijid.2021.04.065","article-title":"Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.","volume":"108","author":"Lagi","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"2","key":"zoi220987r36","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1128\/jvi.65.2.968-971.1991","article-title":"Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines.","volume":"65","author":"Simon","year":"1991","journal-title":"J Virol"},{"issue":"10","key":"zoi220987r37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/jcm6100094","article-title":"Diagnostic accuracy of FebriDx: a rapid test to detect immune responses to viral and bacterial upper respiratory infections.","volume":"6","author":"Self","year":"2017","journal-title":"J Clin Med"},{"issue":"4","key":"zoi220987r38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/02813430802214470","article-title":"Bacterial superinfection in upper respiratory tract infections estimated by increases in CRP values: a diagnostic follow-up in primary care.","volume":"26","author":"Lingard","year":"2008","journal-title":"Scand J Prim Health Care"},{"issue":"322","key":"zoi220987r39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad6873","article-title":"Host gene expression classifiers diagnose acute respiratory illness etiology.","volume":"8","author":"Tsalik","year":"2016","journal-title":"Sci Transl Med"},{"issue":"2","key":"zoi220987r40","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1128\/JCM.36.2.539-542.1998","article-title":"Viruses and bacteria in the etiology of the common cold.","volume":"36","author":"M\u00e4kel\u00e4","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"5","key":"zoi220987r41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults.","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"zoi220987r1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-3-030-26961-6_28","volume-title":"Pediatric Respiratory Diseases","author":"Avenda\u00f1o Carvajal","year":"2020"},{"key":"zoi220987r10","volume-title":"Improving Antibiotic Prescribing for Uncomplicated Acute Respiratory Tract Infections: Comparative Effectiveness Reviews, No. 163","author":"McDonagh","year":"2016"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2797455\/shapiro_2022_oi_220987_1665165494.56222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T15:26:09Z","timestamp":1666106769000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2797455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.34588","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]}}}